BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Defibrillators Cut Cardiac Death by Third, Academic Medical Center Study


8/7/2012 7:45:47 AM

Implantable cardioverter defibrillators account for one-third of the decrease in cardiac arrests caused by ventricular fibrillation in North-Holland, according to research in Circulation, an American Heart Association journal.

VF is an abnormal heart rhythm that makes the heart quiver so it can’t pump blood.

ICDs are small electronic devices implanted in the chest that detect potentially fatal abnormal heart rhythms and try to stop them with electric shocks. Generally, only people with a high risk of sudden cardiac death — mostly those at high risk of abnormal heartbeats and survivors of a previous cardiac arrest — receive ICDs.

Previous studies have shown a gradual 15-year decrease in VF-related cardiac arrests suffered outside the hospital setting — from 54 percent to 38 percent in the United States and Europe. However, the incidence of such cardiac arrests from other abnormal heart rhythms continues to increase each year.

Researchers estimated that ICDs prevented 81 cardiac arrests during the 2005-2008 study. To reach this estimate, they multiplied the number of life-threatening abnormal heart rhythms stopped by an ICD by the probability that the rhythm would have led to a call to emergency medical services (EMS) and a resuscitation attempt.

They assumed that a life-threatening abnormal heart rhythm would prompt calls to EMS in 62 percent of cases, and an attempt at resuscitation would occur in 67 percent of those people.

“At least one in 20 ICD carriers can expect a life-saving shock from their device each year,” said Rudolph W. Koster, M.D., Ph.D., senior author and associate professor of cardiology at the Academic Medical Center in Amsterdam, The Netherlands.

Researchers used data from the Amsterdam Resuscitation Studies registry of cardiac resuscitations by EMS in the greater Amsterdam area in 1995-1997, and all EMS cardiac arrest interventions in the area in 2005-2008.

Focusing on people known to have VF when EMS arrived, researchers found: • An estimated 339 shocks successfully stopped 194 instances of life-threatening abnormal heart rhythms in 166 people. • The percentage of patients with VF cardiac arrest fell from 63 percent in 1995-1997 to 47 percent in 2005-2008. • The annual incidence of VF cardiac arrests fell significantly, from 21.1 people per 100,000 to 17.4 people per 100,000. • Incidence of cardiac arrests related to other abnormal rhythms increased significantly, from 12.2 per 100,000 to 19.4 per 100,000 annually. It’s unknown what caused the other two-thirds of decline in VF arrests or why cardiac arrests vs. other abnormal heart rhythms have increased.

“The possible mechanisms are only guesses without much solid evidence,” Koster said.

It’s likely that western countries that implant ICDs for similar indications would see a similar reduction in out-of-hospital cardiac arrest from ventricular fibrillation, he said.

Co-author are: Michiel Hulleman, M.Sc.; Jocelyn Berdowski, Ph.D.; Joris R. de Groot, M.D., Ph.D.; Pascal F.H.M van Dessel, M.D., Ph.D.; C. Jan Willem Borleffs, M.D., Ph.D.; Marieke T. Blom, M.A.; Abdenasser Bardai, M.D.; Carel C. de Cock, M.D., Ph.D.; Hanno L. Tan, M.D., Ph.D.; Jan G.P. Tijssen, Ph.D. and Rudolph W. Koster, M.D., Ph.D. Author disclosures are on the manuscript.

Although the study received no outside funding, the ARREST database is maintained by an unconditional grant of Physio Control Inc. and a grant from the Netherlands Heart Foundation.

Read the latest guidelines for the use of ICDs.

Read at News Release
Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->